HIV/AIDS

Selected Books and Book Chapters:

1. Carpenter CC, Flanigan T, Lederman MM (2000). "HIV Infection and the Acquired Immunodeficiency Syndrome (Chapter)." In: Andreoli T, Carpenter CC, et al. (Ed.), Cecil Essentials of Medicine, 5th Edition. Philadelphia, W.B. Saunders Co.

2. Tashima K, Flanigan T (2000). "Antiretroviral Therapy in the Year 2000. Infectious Disease Clinics of North America." In: Mayer K (Ed.), Philadelphia, W.B. Saunders Co.: 14(14) 827-849.

3. Wachtel TJ, Stein M (2000). "HIV Infection in Older People (Chapter)." In: Gallo J, Busby-Whitehead J, et al. (Ed.), Reichel’s Care of the Elderly: Clinical Aspects of Aging, 5th Edition. Hagerstown, M.D., Lippincott Williams & Wilkins.

4. Carpenter CC, Flanigan T, Lederman MM (2003). "HIV Infection and the Acquired Immunodeficiency Syndrome (Chapter)." In: Andreoli T, Carpenter CC, et al. (Ed.), Cecil Essentials of Medicine, 6th Edition. Philadelphia, W.B. Saunders Co.

5. De Groot AS, Liebel S (2003). "Women in Prison. A Standard of HIV Care (Chapter)." In: Altice F, Selwyn PA, et al. (Ed.), Reaching In, Reaching Out: Treating HIV/AIDS in the Correctional Community. Chicago, National Commission on Correctional Healthcare (NCCHC): 209-223.

6. Holmes L, Mitty J, Flanigan T (2003). "Project Bridge; Combining Case Management with Peer Support (Chapter)." In: Altice F, Selwyn PA, et al. (Ed.), Reaching In, Reaching Out: Treating HIV/AIDS in the Correctional Community. Chicago, National Commission on Correctional Healthcare (NCCHC): 209-223.

7. Libman H, Stein M (2003). "Primary Care and Prevention of HIV Disease (Chapter)." In: Libman H, Makadon H (Ed.), HIV, Third Edition. American College of Physicians -- American Society of Internal Medicine: 39-76.

8. Maddow R, De Groot AS (2005). "HIV Infection in Incarcerated Women (Chapter)." In: Braithwaite K, Arriola KJ, et al. (Ed.), Health Issues of Incarcerated Women. Rutgers University Press: 209-223.

9. Pizer HF, Mayer K (2005). The AIDS Pandemic: Impact on Science and Society. San Diego, Elsevier Academic Press.

10. Cu Uvin S, Bardeguez A, Chibwesha C (2006). "Vertical Transmission of HIV and Therapeutic Interventions (NRTIs and NNRTIs) (Chapter)." In: Skowron G, Ogden R (Ed.), Reverse Transcriptase Inhibitors in HIV/AIDS Therapy. Humana Press: 425-470.

11. Powrie R, Cu Uvin S (2006). "HIV Infection in Special Populations: HIV Infection in Women." In: Libman H (Ed.), American College of Physicians.

12. Taylor L, Schwartzapfel B, Gholam PM (2006). "Limiting Harm from Chronic Hepatitis C Infection for HIV-Positive People with Drug Dependency: Prevention and Treatment." In: Pizer HF, Mayer K (Ed.), Delivering HIV Care and Treatment for People Who Use Drugs: Lessons from Research and Practice. New York, N.Y., Open Society Institute: 95-109.

13. Greifinger R, Lincoln T, Clear T, et al. (2007). "Screening for Public Purpose: Promoting an Evidence-based Approach to Screening of Inmates to Improve Public Health (Chapter)." In: Greifinger R (Ed.), Public Health Behind Bars: From Prisons to Communities. New York, Springer Publishing.

14. Nijhawan A, Zaller N, Cohen D, et al. (2008). "Interventions with Incarcerated Persons (Chapter)." In: Pizer HF, Mayer K (Ed.), HIV Prevention. San Diego, Elsevier Academic Press.

Peer-Reviewed Publications:

1. Carpenter CC, Mayer KH. (1988). "Advances in AIDS and HIV infection." Adv Intern Med 33:45-79.

2. Carpenter CC, Mayer KH, Stein MD, et al. (1991). "Human immunodeficiency virus infection in North American women: experience with 200 cases and a review of the literature." Medicine (Baltimore) 70(5):307-325.

3. Stein MD, Piette J, Mor V, et al. (1991). "Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons." J Gen Intern Med 6(1):35-40.

4. Flanigan TP, Carpenter CC, Close M. (1992). "HIV infection in the workplace: protecting the vulnerable." Ann Intern Med 117(3):267.

5. Mayer KH, Carpenter CC. (1992). "Women and AIDS." Sci Am 266(3):96.

6. Dixon PS, Flanigan TP, DeBuono BA, et al. (1993). "Infection with the human immunodeficiency virus in prisoners: meeting the health care challenge." Am J Med 95(6):629-635.

7. Flanigan TP, Cu-Uvin S, Fiore T, et al. (1993). "HIV infection in Rhode Island women." R I Med 76(9):459-460, 465-456.

8. Rich JD, Buck A, Tuomala RE, et al. (1993). "Transmission of human immunodeficiency virus infection presumed to have occurred via female homosexual contact." Clin Infect Dis 17(6):1003-1005.

9. Rich JD, Sax PE, Kazanjian PH. (1993). "Bacteremic H. influenzae type b infections and HIV." Am J Med 95(1):118-119.

10. Sande MA, Carpenter CC, Cobbs CG, et al. (1993). "Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients." JAMA 270(21):2583-2589.

11. Hoy JF, Flanigan TP. (1994). "Wasting associated with cocaine and heroin use in patients infected with human immunodeficiency virus." Clin Infect Dis 19(1):209-210.

12. Flanigan TP. (1995). "HIV testing in prison." Lancet 345(8946):390.

13. Carpenter CC, Fischl MA, Hammer SM, et al. (1996). "Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA." JAMA 276(2):146-154.

14. Cu-Uvin S, Flanigan TP, Rich JD, et al. (1996). "Human immunodeficiency virus infection and acquired immunodeficiency syndrome among North American women." Am J Med 101(3):316-322.

15. Elliot BC, Rogers M, Rich JD. (1996). "Indeterminate results of HIV testing: explanation and clinical management." Med Health R I 79(10):360-362.

16. Flanigan TP, Uvin SC, Rich JD, et al. (1996). "Update of HIV and AIDS in North America." Med Health R I 79(5):180-187.

17. Lewis DC, Rich JD. (1996). "Physicians should support needle exchange in Rhode Island." Med Health R I 79(6):206.

18. Carpenter CC, Fischl MA, Hammer SM, et al. (1997). "Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel." JAMA 277(24):1962-1969.

19. Farrar DJ, Flanigan TP, Gordon NM, et al. (1997). "Tuberculous brain abscess in a patient with HIV infection: case report and review." Am J Med 102(3):297-301.

20. Feller A, Flanigan TP. (1997). "HIV-infected competitive athletes. What are the risks? What precautions should be taken?" J Gen Intern Med 12(4):243-246.

21. Pugatch D, Rich JD, Flanigan TP. (1997). "HIV infection in Rhode Island adolescents." Med Health R I 80(10):331-333.

22. Rich JD, Chin-Hong PV, Busi KA, et al. (1997). "Hepatitis C and HIV in male prisoners." J Acquir Immune Defic Syndr Hum Retrovirol 16(5):408-409.

23. Rich JD, Nizam R, Das K, et al. (1997). "HIV and syphilis prevalence in chittagong, Bangladesh." AIDS 11(5):703-704.

24. Rich JD, Ramratnam B, Chiang M, et al. (1997). "Management of indinavir associated nephrolithiasis." J Urol 158(6):2228.

25. Rich JD, Ramratnam B, Flanigan TP. (1997). "Triple combination antiretroviral prophylaxis for needlestick exposure to HIV." Infect Control Hosp Epidemiol 18(3):161.

26. Rich JD, Sullivan T, Greineder D, et al. (1997). "Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons." Ann Allergy Asthma Immunol 79(5):409-414.

27. Ruiz R, Cu-Uvin S, Fiore T, et al. (1997). "Toxoplasmosis in HIV-positive women: seroprevalence and the role of prophylaxis in preventing disease." AIDS 11(1):119-120.

28. Stein MD, Hanna L. (1997). "Use of mental health services by HIV-infected women." J Womens Health 6(5):569-574.

29. Uvin SC, Flanigan TP. (1997). "Human immunodeficiency virus infection and sexually transmitted diseases." Med Health R I 80(10):334-337.

30. Carpenter CC, Fischl MA, Hammer SM, et al. (1998). "Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel." JAMA 280(1):78-86.

31. Conklin TJ, Lincoln T, Flanigan TP. (1998). "A public health model to connect correctional health care with communities." Am J Public Health 88(8):1249-1250.

32. Cu Uvin S, Caliendo AM, Reinert SE, et al. (1998). "HIV-1 in the female genital tract and the effect of antiretroviral therapy." AIDS 12(7):826-827.

33. Dickinson BP, Mitty JA, Mylonakis E, et al. (1998). "Predictors of undetectable HIV plasma viral load in 250 HIV-positive women receiving care." AIDS 12(15):2075-2076.

34. Mylonakis E, Koutkia P, Rich JD, et al. (1998). "Substance abuse is responsible for most pre-AIDS deaths among women with HIV infection in Providence, Rhode Island, USA." AIDS 12(8):958-959.

35. Pugatch D, Mileno M, Rich JD. (1998). "Possible transmission of human immunodeficiency virus type 1 from body piercing." Clin Infect Dis 26(3):767-768.

36. Rich JD, Dickinson BP, Carney JM, et al. (1998). "Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection." AIDS 12(17):2345-2350.

37. Rich JD, Dickinson BP, Liu KL, et al. (1998). "Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users." J Acquir Immune Defic Syndr Hum Retrovirol 18 Suppl 1:S140-141.

38. Rich JD, Dickinson BP, Merriman NA, et al. (1998). "Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter." Am J Gastroenterol 93(9):1598.

39. Rich JD, Dickinson BP, Spaulding A, et al. (1998). "Interpretation of indeterminate HIV serology results in an incarcerated population." J Acquir Immune Defic Syndr Hum Retrovirol 17(4):376-379.

40. Stein MD, Freedberg KA, Sullivan LM, et al. (1998). "Sexual ethics. Disclosure of HIV-positive status to partners." Arch Intern Med 158(3):253-257.

41. Tashima KT. (1998). "Cerebrospinal fluid levels of antiretroviral medications: abstract and commentary." JAMA 280(10):879-880.

42. Chodock R, Mylonakis E, Shemin D, et al. (1999). "Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis--role of haemodialysis treatment." Nephrol Dial Transplant 14(10):2484-2486.

43. Flanigan TP, Hogan JW, Smith D, et al. (1999). "Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection." Clin Infect Dis 29(3):608-612.

44. Flanigan TP, Rich JD, Spaulding A. (1999). "HIV care among incarcerated persons: a missed opportunity." AIDS 13(17):2475-2476.

45. Mitty JA, McKenzie M, Stenzel M, et al. (1999). "Modified directly observed therapy for treatment of human immunodeficiency virus." JAMA 282(14):1334.

46. Mylonakis E, Dickinson BP, Mileno MD, et al. (1999). "Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy." Am J Hematol 60(2):164-166.

47. Rich JD, Dickinson BP, Macalino G, et al. (1999). "Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island." J Acquir Immune Defic Syndr 22(2):161-166.

48. Rich JD, Merriman NA, Mylonakis E, et al. (1999). "Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series." Ann Intern Med 130(1):37-39.

49. Rich JD, Strong L, Towe CW, et al. (1999). "Obstacles to needle exchange participation in Rhode Island." J Acquir Immune Defic Syndr 21(5):396-400.

50. Spaulding AC, Lally M, Rich JD, et al. (1999). "Hepatitis B and C in the context of HIV disease: implications for incarcerated populations." AIDS Read 9(7):481-491.

51. Staszewski S, Morales-Ramirez J, Tashima KT, et al. (1999). "Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team." N Engl J Med 341(25):1865-1873.

52. Stein MD. (1999). "Medical consequences of substance abuse." Psychiatr Clin North Am 22(2):351-370.

53. Stein MD, Samet JH. (1999). "Disclosure of HIV status." AIDS Patient Care STDS 13(5):265-267.

54. Tashima KT, Caliendo AM, Ahmad M, et al. (1999). "Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy." J Infect Dis 180(3):862-864.

55. Vigilante KC, Flynn MM, Affleck PC, et al. (1999). "Reduction in recidivism of incarcerated women through primary care, peer counseling, and discharge planning." J Womens Health 8(3):409-415.

56. Williams SB, Flanigan TP, Artenstein AW, et al. (1999). "CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection." J Infect Dis 179(5):1310-1312.

57. Willy RJ, Salas CM, Macalino GE, et al. (1999). "Long-term non-progression of HIV-1 in a patient coinfected with HTLV-II." Diagn Microbiol Infect Dis 35(4):269-270.

58. Burris S, Lurie P, Abrahamson D, et al. (2000). "Physician prescribing of sterile injection equipment to prevent HIV infection: time for action." Ann Intern Med 133(3):218-226.

59. Carpenter CC, Cooper DA, Fischl MA, et al. (2000). "Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel." JAMA 283(3):381-390.

60. Cu-Uvin S, Caliendo AM, Reinert S, et al. (2000). "Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA." AIDS 14(4):415-421.

61. Farley JL, Mitty JA, Lally MA, et al. (2000). "Comprehensive medical care among HIV-positive incarcerated women: the Rhode Island experience." J Womens Health Gend Based Med 9(1):51-56.

62. Feller AA, Flanigan TP. (2000). "HIV, infectious diseases, and competitive athletics." Med Health R I 83(2):56-59.

63. Harrington M, Carpenter CC. (2000). "Hit HIV-1 hard, but only when necessary." Lancet 355(9221):2147-2152.

64. Mylonakis E, Paliou M, Greenbough TC, et al. (2000). "Report of a false-positive HIV test result and the potential use of additional tests in establishing HIV serostatus." Arch Intern Med 160(15):2386-2388.

65. Osowiecki DM, Cohen RA, Morrow KM, et al. (2000). "Neurocognitive and psychological contributions to quality of life in HIV-1-infected women." AIDS 14(10):1327-1332.

66. Stein MD, Rich JD, Maksad J, et al. (2000). "Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use." Am J Drug Alcohol Abuse 26(2):195-205.

67. Stein MD, Urdaneta ME, Clarke J, et al. (2000). "Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance." J Addict Dis 19(1):85-94.

68. Stenzel MS, Carpenter CC. (2000). "The management of the clinical complications of antiretroviral therapy." Infect Dis Clin North Am 14(4):851-878, vi.

69. Tashima KT, Fiore TC. (2000). "Sustained responses to dual nucleoside therapy in women." J Acquir Immune Defic Syndr 25(4):371-372.

70. Tashima KT, Flanigan TP. (2000). "Antiretroviral therapy in the year 2000." Infect Dis Clin North Am 14(4):827-849.

71. Cannon MJ, Dollard SC, Smith DK, et al. (2001). "Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection." N Engl J Med 344(9):637-643.

72. Clarke JG, Stein MD, Hanna L, et al. (2001). "Active and Former Injection Drug Users Report of HIV Risk Behaviors During Periods of Incarceration." Subst Abus 22(4):209-216.

73. Cohen RA, Boland R, Paul R, et al. (2001). "Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women." AIDS 15(3):341-345.

74. Collier AC, Kalish LA, Busch MP, et al. (2001). "Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial." JAMA 285(12):1592-1601.

75. Cu-Uvin S, Hogan JW, Caliendo AM, et al. (2001). "Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract." Clin Infect Dis 33(6):894-896.

76. Flanigan T, Tashima KT. (2001). "Diagnosis of acute HIV infection: it's time to get moving!" Ann Intern Med 134(1):75-77.

77. Mileno MD, Barnowski C, Fiore T, et al. (2001). "Factitious HIV syndrome in young women." AIDS Read 11(5):278-282.

78. Mylonakis E, Paliou M, Rich JD. (2001). "Plasma viral load testing in the management of HIV infection." Am Fam Physician 63(3):483-490, 495-486.

79. Pugatch D, Levesque B, Greene S, et al. (2001). "HIV testing in the setting of inpatient acute substance abuse treatment." Am J Drug Alcohol Abuse 27(3):491-499.

80. Pugatch DL, Levesque BG, Lally MA, et al. (2001). "HIV testing among young adults and older adolescents in the setting of acute substance abuse treatment." J Acquir Immune Defic Syndr 27(2):135-142.

81. Rich JD, Holmes L, Salas C, et al. (2001). "Successful linkage of medical care and community services for HIV-positive offenders being released from prison." J Urban Health 78(2):279-289.

82. Rich JD, Jenny-Avital E. (2001). "Less than optimal?" AIDS Clin Care 13(7):66-67, 70.

83. Rich JD, Macalino GE, McKenzie M, et al. (2001). "Syringe prescription to prevent HIV infection in Rhode Island: a case study." Am J Public Health 91(5):699-700.

84. Rich JD, McKenzie M, Macalino G, et al. (2001). "The genesis of syringe prescription to prevent HIV in Rhode Island." Health Matrix Clevel 11(1):129-145.

85. Rich JD, Whitlock TL, Towe CW, et al. (2001). "Prescribing syringes to prevent HIV: a survey of infectious disease and addiction medicine physicians in Rhode Island." Subst Use Misuse 36(5):535-550.

86. Stenzel MS, McKenzie M, Mitty JA, et al. (2001). "Enhancing adherence to HAART: a pilot program of modified directly observed therapy." AIDS Read 11(6):317-319, 324-318.

87. Tashima KT, Hogan JW, Gardner LI, et al. (2001). "A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use." Clin Infect Dis 33(12):2055-2060.

88. Thomas DL, Rich JD, Schuman P, et al. (2001). "Multicenter evaluation of hepatitis C RNA levels among female injection drug users." J Infect Dis 183(6):973-976.

89. Beckwith CG, Lally MA, Flanigan TP. (2002). "Routine HIV testing among inpatients." Arch Intern Med 162(19):2252-2253; author reply 2253.

90. Desai AA, Latta ET, Spaulding A, et al. (2002). "The importance of routine HIV testing in the incarcerated population: the Rhode Island experience." AIDS Educ Prev 14(5 Suppl B):45-52.

91. DiRienzo AG, van Der Horst C, Finkelstein DM, et al. (2002). "Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection." AIDS Res Hum Retroviruses 18(2):89-94.

92. Falloon J, Ait-Khaled M, Thomas DA, et al. (2002). "HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients." AIDS 16(3):387-396.

93. Feller E, Taylor LE. (2002). "Ten things you may not know about hepatitis C infection." Med Health R I 85(6):180-181.

94. Howard AA, Arnsten JH, Lo Y, et al. (2002). "A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women." AIDS 16(16):2175-2182.

95. Kumarasamy N, Flanigan TP, Mahajan AP, et al. (2002). "Monitoring HIV treatment in the developing world." Lancet Infect Dis 2(11):656-657.

96. Kumarasamy N, Mahajan AP, Flanigan TP, et al. (2002). "Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries." J Acquir Immune Defic Syndr 31(4):378-383.

97. Rich JD, Macalino G, Merchant RC, et al. (2002). "HIV seroprevalence of adult males incarcerated for a sexual offense in Rhode Island, 1994-1999." JAMA 288(2):164-165.

98. Rich JD, Wolf FA, Macalino G. (2002). "Strategies to improve access to sterile syringes for injection drug users." AIDS Read 12(12):527-535.

99. Spaulding A, Stephenson B, Macalino G, et al. (2002). "Human immunodeficiency virus in correctional facilities: a review." Clin Infect Dis 35(3):305-312.

100. Stein MD, Anderson B, Charuvastra A, et al. (2002). "A brief intervention for hazardous drinkers in a needle exchange program." J Subst Abuse Treat 22(1):23-31.

101. Stein MD, Charuvastra A, Anderson B, et al. (2002). "Alcohol and HIV risk taking among intravenous drug users." Addict Behav 27(5):727-736.

102. Stein MD, Friedmann P. (2002). "Need for medical and psychosocial services among injection drug users: a comparative study of needle exchange and methadone maintenance." Am J Addict 11(4):262-270.

103. Tashima KT, Flanigan TP, Kurpewski J, et al. (2002). "Discordant Human Immunodeficiency Virus Type 1 drug resistance mutations, including K103N, observed in cerebrospinal fluid and plasma." Clin Infect Dis 35(1):82-83.

104. Taylor LE, Costello T, Alt E, et al. (2002). "Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals." AIDS 16(12):1700-1701.

105. Williams SB, Flanigan TP, Cu-Uvin S, et al. (2002). "Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1." Clin Infect Dis 35(5):611-617.

106. Yeni PG, Hammer SM, Carpenter CC, et al. (2002). "Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel." JAMA 288(2):222-235.

107. Harwell JI, Flanigan TP, Mitty JA, et al. (2003). "Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence." AIDS 17(13):1990-1993.

108. Hicks CB, Beckwith CG, Mitty J, et al. (2003). "Confronting the clinical uncertainty regarding syphilis." AIDS Clin Care 15(7):64-65.

109. Kumarasamy N, Solomon S, Chaguturu SK, et al. (2003). "The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India." AIDS 17(15):2267-2269.

110. Kumarasamy N, Solomon S, Flanigan TP, et al. (2003). "Natural history of human immunodeficiency virus disease in southern India." Clin Infect Dis 36(1):79-85.

111. Macalino GE, Ko H, Celentano DD, et al. (2003). "Drug use patterns over time among HIV-seropositive and HIV-seronegative women: the HER study experience." J Acquir Immune Defic Syndr 33(4):500-505.

112. Mayer KH, Hogan JW, Smith D, et al. (2003). "Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy." J Acquir Immune Defic Syndr 33(5):614-624.

113. Mitty JA, Macalino G, Taylor L, et al. (2003). "Directly observed therapy (DOT) for individuals with HIV: successes and challenges." MedGenMed 5(1):30.

114. Powderly WG, Mayer KH. (2003). "Centers for Disease Control and Prevention revised guidelines for human immunodeficiency virus (HIV) counseling, testing, and referral: targeting HIV specialists." Clin Infect Dis 37(6):813-819.

115. Rich JD, Taylor L, Mehrotra M, et al. (2003). "Prescribing syringes to injection drug users: what the family physician should know." Am Fam Physician 68(1):45-47.

116. Simmons E, Lally MA, Flanigan TP. (2003). "Routine, not risk-based, human immunodeficiency virus testing is the way to go." J Infect Dis 187(6):1024.

117. Simmons EM, Flanigan TP. (2003). "Point of view: the rapid spread of HIV among minority communities in the United States: a call to action." Med Health R I 86(3):83-85.

118. Stein MD, Solomon DA, Herman DS, et al. (2003). "Depression severity and drug injection HIV risk behaviors." Am J Psychiatry 160(9):1659-1662.

119. Tashima KT, Alt EN, Harwell JI, et al. (2003). "Internet sex-seeking leads to acute HIV infection: a report of two cases." Int J STD AIDS 14(4):285-286.

120. Tashima KT, Bausserman L, Alt EN, et al. (2003). "Lipid changes in patients initiating efavirenz- and indinavir-based antiretroviral regimens." HIV Clin Trials 4(1):29-36.

121. Tashima KT, Carpenter CC. (2003). "Fusion inhibition--a major but costly step forward in the treatment of HIV-1." N Engl J Med 348(22):2249-2250.

122. Tate D, Paul RH, Flanigan TP, et al. (2003). "The impact of apathy and depression on quality of life in patients infected with HIV." AIDS Patient Care STDS 17(3):115-120.

123. Taylor LE, Runarsdottir V, Zampi A, et al. (2003). "Would you consider prescribing syringes to injection drug users? Addiction Medicine Conference Survey." J Addict Dis 22(1):67-78.

124. Taylor LE, Schwartzapfel B, Allen S, et al. (2003). "Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence." Clin Infect Dis 36(11):1501-1502; author reply 1502-1503.

125. Boutwell A, Rich JD. (2004). "HIV infection behind bars." Clin Infect Dis 38(12):1761-1763.

126. Boutwell A, Rich JD. (2004). "Syringe access for injection drug users in Rhode Island." Med Health R I 87(1):15-16.

127. De Groot AS, Bishop EA, Khan B, et al. (2004). "Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine." Methods 34(4):476-487.

128. Kumarasamy N, Chaguturu S, Mayer KH, et al. (2004). "Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India." J Acquir Immune Defic Syndr 37(5):1574-1576.

129. Kwara A, Carter EJ, Rich JD, et al. (2004). "Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients." AIDS Patient Care STDS 18(6):341-347.

130. Lurie MN, Carter EJ, Cohen J, et al. (2004). "Directly observed therapy for HIV/tuberculosis co-infection." Lancet Infect Dis 4(3):137-138.

131. Macalino GE, Vlahov D, Sanford-Colby S, et al. (2004). "Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons." Am J Public Health 94(7):1218-1223.

132. Mayer KH, Safren SA, Gordon CM. (2004). "HIV care providers and prevention: opportunities and challenges." J Acquir Immune Defic Syndr 37 Suppl 2:S130-132.

133. Mitty JA, Flanigan TP. (2004). "Community-based interventions for marginalized populations." Clin Infect Dis 38 Suppl 5:S373-375.

134. Rich JD, McKenzie M, Macalino GE, et al. (2004). "A syringe prescription program to prevent infectious disease and improve health of injection drug users." J Urban Health 81(1):122-134.

135. Rompalo AM, Shah N, Margolick JB, et al. (2004). "Evaluation of possible effects of continued drug use on HIV progression among women." Int J STD AIDS 15(5):322-327.

136. Stozek MA, Taylor LE, LeBreux L, et al. (2004). "Prescribing syringes to injection drug users with HIV: an important clinical and public health tool." J Assoc Nurses AIDS Care 15(2):59-63.

137. Taylor LE, Rich JD, Tashima KT. (2004). "Peginterferon plus ribavirin for hepatitis C in HIV-infected patients." N Engl J Med 351(22):2340-2342; author reply 2340-2342.

138. Yeni PG, Hammer SM, Hirsch MS, et al. (2004). "Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel." JAMA 292(2):251-265.

139. Beckwith CG, Flanigan TP, del Rio C, et al. (2005). "Screening for HIV." Ann Intern Med 143(12):916; discussion 916-917.

140. Beckwith CG, Flanigan TP, del Rio C, et al. (2005). "It is time to implement routine, not risk-based, HIV testing." Clin Infect Dis 40(7):1037-1040.

141. Boutwell AE, Allen SA, Rich JD. (2005). "Opportunities to address the hepatitis C epidemic in the correctional setting." Clin Infect Dis 40 Suppl 5:S367-372.

142. Edlin BR, Kresina TF, Raymond DB, et al. (2005). "Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users." Clin Infect Dis 40 Suppl 5:S276-285.

143. Flanigan TP, Campbell T, Harwell J, et al. (2005). "The extraordinary hope of antiretroviral therapy in South Africa (even for patients with tuberculosis or kaposi sarcoma!)." J Infect Dis 191(3):321-323.

144. Flanigan TP, Taylor LE, Mitty JA. (2005). "Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection." Clin Infect Dis 40 Suppl 5:S346-348.

145. Henry K, Bartlett JA, Kojic E, et al. (2005). "Antiretroviral rounds. A communication conundrum." AIDS Clin Care 17(12):115-116.

146. Henry PC, Rich JD. (2005). "Editorial comment: the complexities of homelessness and HIV." AIDS Read 15(11):613.

147. Kumarasamy N, Solomon S, Chaguturu SK, et al. (2005). "The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India." Clin Infect Dis 41(10):1525-1528.

148. Kumarasamy N, Vallabhaneni S, Cecelia AJ, et al. (2005). "Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy." J Acquir Immune Defic Syndr 40(3):377-378.

149. Kumarasamy N, Vallabhaneni S, Flanigan TP, et al. (2005). "Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients." AIDS 19(6):625-627.

150. Kumarasamy N, Vallabhaneni S, Flanigan TP, et al. (2005). "Clinical profile of HIV in India." Indian J Med Res 121(4):377-394.

151. Kwara A, Flanigan TP, Carter EJ. (2005). "Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status." Int J Tuberc Lung Dis 9(3):248-257.

152. Lally MA, MacNevin R, Sergie Z, et al. (2005). "A model to provide comprehensive testing for HIV, viral hepatitis, and sexually transmitted infections at a short-term drug treatment center." AIDS Patient Care STDS 19(5):298-305.

153. Mitty JA, Macalino GE, Bazerman LB, et al. (2005). "The use of community-based modified directly observed therapy for the treatment of HIV-infected persons." J Acquir Immune Defic Syndr 39(5):545-550.

154. Paul R, Flanigan TP, Tashima K, et al. (2005). "Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus." J Neuropsychiatry Clin Neurosci 17(1):114-118.

155. Paul RH, Brickman AM, Navia B, et al. (2005). "Apathy is associated with volume of the nucleus accumbens in patients infected with HIV." J Neuropsychiatry Clin Neurosci 17(2):167-171.

156. Rich JD, McKenzie M, Shield DC, et al. (2005). "Linkage with methadone treatment upon release from incarceration: a promising opportunity." J Addict Dis 24(3):49-59.

157. Rosengard C, Clarke JG, DaSilva K, et al. (2005). "Correlates of partner-specific condom use intentions among incarcerated women in Rhode Island." Perspect Sex Reprod Health 37(1):32-38.

158. Simmons EM, Rogers ML, Frierson GM, et al. (2005). "Racial/ethnic attitudes towards HIV testing in the primary care setting." J Natl Med Assoc 97(1):46-52.

159. Spaete JP, Rich JD. (2005). "HIV prevention and care in incarcerated populations." Focus 20(8):1-5.

160. Swindells S, Cohen CJ, Berger DS, et al. (2005). "Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens." BMC Infect Dis 5(1):23.

161. Taylor LE. (2005). "Delivering care to injection drug users coinfected with HIV and hepatitis C virus." Clin Infect Dis 40 Suppl 5:S355-361.

162. Taylor LE, Gholam PM, Schwartzapfel B, et al. (2005). "Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report." AIDS Read 15(11):629-631, 634-626, 638.

163. Zaller N, Noak A, Poshkus M, et al. (2005). "The overlapping epidemics of viral hepatitis/HIV, addiction and incarceration: the situation in Rhode Island." Med Health R I 88(12):424-427.

164. Beckwith CG, Moreira CC, Aboshady HM, et al. (2006). "A success story: HIV prevention for injection drug users in Rhode Island." Subst Abuse Treat Prev Policy 1:34.

165. Carpenter CC. (2006). "Universal access to antiretroviral therapy: when, not if." Clin Infect Dis 42(2):260-261.

166. Flanigan TP, Beckwith C, Carpenter CC. (2006). "Public health principles for the HIV epidemic." N Engl J Med 354(8):877-878; author reply 877-878.

167. Flanigan TP, Mitty JA. (2006). "The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult." Clin Infect Dis 42(11):1636-1638.

168. Hammer SM, Saag MS, Schechter M, et al. (2006). "Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel." Top HIV Med 14(3):827-843.

169. Hammer SM, Saag MS, Schechter M, et al. (2006). "Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel." JAMA 296(7):827-843.

170. Kumar PN, Rodriguez-French A, Thompson MA, et al. (2006). "A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity." HIV Med 7(2):85-98.

171. Kumarasamy N, Vallabhaneni S, Cecelia AJ, et al. (2006). "Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India." J Acquir Immune Defic Syndr 41(1):53-58.

172. Lai AR, Tashima KT, Taylor LE. (2006). "Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virus." AIDS Patient Care STDS 20(10):678-692.

173. Margolis AD, MacGowan RJ, Grinstead O, et al. (2006). "Unprotected sex with multiple partners: implications for HIV prevention among young men with a history of incarceration." Sex Transm Dis 33(3):175-180.

174. McGovern BH, Ditelberg JS, Taylor LE, et al. (2006). "Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients." Clin Infect Dis 43(3):365-372.

175. Payne NS, Beckwith CG, Davis M, et al. (2006). "Acceptance of HIV testing among African-American college students at a historically black university in the south." J Natl Med Assoc 98(12):1912-1916.

176. Pugatch D, Anderson BJ, O'Connell JV, et al. (2006). "HIV and HCV testing for young drug users in Rhode Island." J Adolesc Health 38(3):302-304.

177. Rich JD, Mitty JA, Beckwith CG. (2006). "Editorial comment: correctional opportunities to address the HIV/AIDS epidemic." AIDS Read 16(5):258.

178. Stein MD, Anderson BJ, Lassor J, et al. (2006). "Receipt of disability payments by substance users: mental and physical health correlates." Am J Addict 15(2):160-165.

179. Tashima KT, Mitty JA. (2006). "Once-daily therapies for the treatment of HIV infection." Curr HIV/AIDS Rep 3(2):86-92.

180. Beckwith CG, Atunah-Jay S, Cohen J, et al. (2007). "Feasibility and acceptability of rapid HIV testing in jail." AIDS Patient Care STDS 21(1):41-47.

181. Beckwith CG, Cohen J, Shannon C, et al. (2007). "HIV testing experiences among male and female inmates in Rhode Island." AIDS Read 17(9):459-464.

182. Beckwith CG, Zaller N, Flanigan TP. (2007). "HIV counseling and testing among injection drug users needs to continue." Am J Public Health 97(7):1161.

183. Cohen DE, Mayer KH. (2007). "Primary care issues for HIV-infected patients." Infect Dis Clin North Am 21(1):49-70, viii.

184. Kacanek D, Eldridge GD, Nealey-Moore J, et al. (2007). "Young incarcerated men's perceptions of and experiences with HIV testing." Am J Public Health 97(7):1209-1215.

185. Kumarasamy N, Flanigan TP, Vallabhaneni S, et al. (2007). "A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India." AIDS Care 19(4):507-513.

186. Lally MA, Lemei K, Bonney LE, et al. (2007). "HPV vaccination an opportune time for HIV testing." J Adolesc Health 40(4):384; author reply 384-385.

187. Macalino GE, Hogan JW, Mitty JA, et al. (2007). "A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users." AIDS 21(11):1473-1477.

188. Rich JD, Hogan JW, Wolf F, et al. (2007). "Lower syringe sharing and re-use after syringe legalization in Rhode Island." Drug Alcohol Depend 89(2-3):292-297.

189. Spaulding AC, Allen SA, Stone A. (2007). "Mortality after release from prison." N Engl J Med 356(17):1785; author reply 1786-1787.

190. Stein MD, Herman DS, Bishop D, et al. (2007). "A telephone-based intervention for depression in HIV patients: negative results from a randomized clinical trial." AIDS Behav 11(1):15-23.

191. Subbaraman R, Chaguturu SK, Mayer KH, et al. (2007). "Adverse effects of highly active antiretroviral therapy in developing countries." Clin Infect Dis 45(8):1093-1101.

192. Zaller N, Dawalt M, Beckwith C, et al. (2007). "Routine HIV testing in US prisons." Lancet Infect Dis 7(7):440-441.

193. Zaller N, Thurmond P, Rich JD. (2007). "Limited spending: an analysis of correctional expenditures on antiretrovirals for HIV-infected prisoners." Public Health Rep 122(1):49-54.